Samsung Electro-Mechanics

https://korean-electronics.com//inquiry

Samsung Electro-Mechanics Invests KRW 1.8 Tril. in Vietnam

Responding to surging demand for AI substrates
Orders from big-tech companies expected to increase

Samsung Electro-Mechanics plans to invest KRW 1 trillion in its Vietnam production base to expand the production of semiconductor substrates, aiming to resolve production-capacity limitations and enhance supply responsiveness amidst the rapidly increasing demand for high-value-added substrates for artificial intelligence (AI).
According to Bloomberg, the company will invest US$ 1.2 billion (approximately KRW 1.8 trillion) to expand production facilities for flip-chip ball greed array (FC-BGA photo) at its Vietnam production base. It has also completed investment registration procedures with the Vietnam Foreign Investment Agency for AI-related FC-BGA production.

This investment is reported as a strategy to restructure its existing production base to focus on high-value-added substrates. FC-BGA is a high-density package substrate in which semiconductor chips are mounted upside down on a substrate and connected by using fine metal balls.
The scale of this investment is comparable to the company’s initial entry into Vietnam in 2013 when it constructed a camera-module and printed circuit board (PCB) plant. This is a trillion-dollar investment made again after 13 years.
It customer base is also expanding quickly. Samsung Electro-Mechanics is supplying substrates to global tech firms such as Broadcom, Google, and Amazon.

The company recently secured a deal to supply FC-BGA to Grock 3 language processing unit (LPU), a dedicated inference chip installed in Nvidia’s next-generation AI semiconductor Vera Rubin, with mass-production expected to begin in the second quarter of this year.
There is also growing speculation that its FC-BGA could be adopted for Tesla’s AI chip, the AI6, signaling further expansion of its big-tech client base.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Samsung and LG Collaborate on Gaming Monitors

https://korean-electronics.com//inquiry

Joining hands in targeting this high-value market against China

Samsung and LG, which have long completed against each other in Korean and global home appliance markets, set in motion an effort to cooperate. According to industry sources, Samsung Electronics Co. has decided to use white (W)-OLED panels made by LG Display Co. in its upcoming OLED gaming monitor, Odyssey G7, set for release this year. This follows LG Electronics Inc.’s decision to adopt quantum dot organic light-emitting diode (AD-OLED) panels from Samsung Display Co. in its gaming monitors scheduled for release in the second half of this year.

It is reported that Samsung Electronics Co. has selected panels from LG Display Co. to expand to OLED its Odyssey G7 monitor lineup, which was originally released last year using LCDs. With reports indicating that Samsung Electronics Co. and LG Display Co. have signed a panel supply contract and commenced full-scale mass-production and set manufacturing early this year. Forecasts suggest it is highly likely to launch in the second quarter of this year.
This collaboration between Samsung and LG is seen as a strategy to counter China, which has emerged as a new threat by leveraging cost-effectiveness and technological advancement.
Demand for gaming monitors in the global market has been increasing every year. Market research firm Omdia forecasts that gaming monitors will account for approximately 35% of total global monitor shipments this year. Also, it is expected that the share of gaming monitor shipments will rise to about 40% by 2029.
In particular, OLED gaming monitors are expected to overtake LCD monitors, which have been the mainstream until now, and establish themselves as the ‘new trend.’ In fact, the revenue share of OLED monitors, which stood at just 1.2% in the total global monitor market in 2022, has expanded to 7.4% in 2023, 13.6% in 2024, and reached 20% last year.
OLEDs are rising in the gaming monitor industry due to their high scan rate and response speed. OLEDs have a self-lighting structure where each individual pixel produces its own light, so they do not have the chronic problems of LCDs ― which include blacklight bleeding, slow response time, and blacklight issues (the phenomenon where black appears gray in dark scenes) ― providing overwhelming contrast ratios and vivid images that appear just like what users see with their own eyes.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

AI semiconductors and glass substrates

https://korean-electronics.com//inquiry

Glass Substrates with Enhanced Power Efficiency Become a Game Changer for AI Semiconductors

Samsung Electro-Mechanics moves to dominate the glass substrate market.

The competition in semiconductor performance is shifting beyond chips to substrates, due to the rapid expansion of artificial intelligence (AI). As data-processing volumes surge, the role of substrates connecting chips has become increasingly critical. Limitations of conventional plastic-based substrates are becoming more evident, positioning glass substrates as an alternative for high-performance applications.
AI semiconductors, in particular, have a structure tightly linking graphic processing units (GPUs) and high bandwidth memory (HBM).

Plastic (organic) substrates that have been widely used so far are increasingly facing structural limitations due to the large-scale, high-performance trends of AI semiconductors. They are more vulnerable to heat, prone to warping at high temperatures, and require additional layers to enhance performance.
Amidst such expectations and limitations, competition in glass substrates is intensifying. SKC’s subsidiary Absolics is considered closest to commercialization, producing prototypes at its Georgia facility in the USA and conducting tests with global clients. LG Innotek is also preparing for mass-production in 2027-2028, based on its pilot production system.

Global companies are joining the race. Intel is seeking to lead the way in technical conversion by significantly expanding substrate size, while China’s BOE is building supply chains through pilot production lines. Japan’s Ibiden is also advancing development, leveraging its leading position in the substrate market.
Samsung Electronics’ affiliates are likewise moving to strengthen their capabilities in glass substrates based on each affiliate’s core competitiveness and role. Rather than a single unified effort, each affiliate is developing technologies that collectively enhance the group’s packaging competitiveness. Samsung Electro-Mechanics is responsible for developing and mass-producing glass substrates. The company is producing prototypes based on a pilot line in its Sejong Plant, and working with Japan’s Sumitomo Chemical Group to secure a supply chain for glass core materials. The company aims to enter mass production after 2027.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Explore the Surroundings of Gyeongbokgung Palace in Hanbok

https://korean-electronics.com//inquiry

Gyeongbokgung Palace is one of the most recognizable cultural heritage and tourist sites in Korea. Once a palace where the kings of the Joseon dynasty resided and ruled the kingdom, its shining presence can still be found amid majestic buildings in the heart of Seoul. The area surrounding the palace is full of experience spaces, exhibition halls, and restaurants beloved by Gen Z. This area can broadly be divided into Seochon and Bukchon areas, centered around different themes. Considering the area’s historical significance, wearing a hanbok as you explore the area can enrich your memory of the visit even further.

Explore the sensibilities of small alleyways in the Seochon area
Seochon is a village west of Gyeongbokgung Palace and can be accessed through Yeongchumun Gate, the western gate of Gyeongbokgung Palace. Once a village occupied by artists, Seochon has a rather humble, unique atmosphere with small, single-story buildings lining the narrow alleyways, in contrast to the glittering splendor of central Seoul. In recent days, Seochon has begun to draw a large crowd of younger visitors with chic and elegant boutiques, galleries, and cafés that renovate the old buildings with contemporary sensibilities.
The first stop in this Seochon trip is Groundseesaw Seochon. This exhibition space became prominent with hip and interesting exhibitions like “Photographs by YOSIGO: Holiday Memories” and “Accidentally Wes Anderson: Inspire. Discover. Adventure Awaits.” The building itself impresses with its architectural merits, which were recognized by the 2020 Seoul Architecture Award. Going inside, one can find a pond and a garden built at the center of the building, creating a peaceful ambience like that in a forest. Just visiting the building, in that sense, is an experience that exceeds one’s expectations.

When emerging from the complex net of alleyways, one finds a two-story residential building with a small signboard. This building houses the Korean branch of “Ofr.,” a French independent bookstore. This seemingly mundane residential building houses a treasure trove of chic and quirky items waiting to be discovered by the discerning shopper. From rare edition books from abroad casually arranged in piles to design posters hung up on walls with peeling paint and colorful tote bags thrown around the space, the interior space exemplifies the casual yet chic ambience that has captivated many members of the Korean Gen Z. For travelers, Ofr. offers T-shirts made in-house, cute accessories, and interior decorations that make for great souvenirs.
In a village awash in retro sensibilities, Dae-o Bookstore stands out as the most analog of its spaces. From the peeling paint of its signboard to the worn organ once belonging to the elderly couple who owned the bookstore, earthenware pots, and furniture adorned with jagae (mother-of-pearl and lacquer craft), this old hanok (traditional Korean house) building contains numerous stories that have accumulated in it since 1951. Its unique ambience led to the interior being featured in the jacket photograph of singer-songwriter IU’s first cover album, “A Flower Bookmark.” Today, Dae-o Bookstore functions as a book café, open to those who order beverages.

A two-minute walk from Dae-o Bookstore brings one to Seochon’s famous Tongin Market, a local market with a hundred-year-long history. The delicious smell from the market makes it difficult to just go past the market. The most famous dish served in the market is the oil tteokbokki, rice cakes seasoned and stir-fried in a hot pan. Unlike other tteokbokki, oil tteokbokki has a thick sauce. The rice cakes become crispy flavor bombs dense with savory flavors, culminating in a unique gourmet experience. Another option is to go for the “Coin Lunchbox,” a DIY lunchbox you can assemble with different dishes offered in Tongin Market. The coins used in exchange replicate the coins used in the Joseon period. Multilingual signage makes the experience accessible to international visitors as well.

Take the pic of the day, with hanok buildings as a backdrop, at the Bukchon area
Bukchon is another tourist site that one can visit in conjunction with Gyeongbokgung Palace. Compared to Seochon, the hanok buildings in Bukchon tend to be much better preserved, and Bukchon also has parks, a café street, and other interesting sights. The gate that originally led to Bukchon was Geonchunmun Gate, the eastern gate of Gyeongbokgung Palace, but today, visitors must use the entrance of the National Folk Museum of Korea instead.
The centerpiece of the Bukchon area is Bukchon Hanok Village. Originally a historic neighborhood occupied by the members of the royal family, yangban (aristocracy), and state officials in the Joseon period, most hanok buildings in the village follow the urban format, which eschews the open arrangement of traditional hanok buildings that reveals the central courtyard to the beholder, instead featuring higher walls that ensure greater privacy. The photo spot at the top of the hill allows one to capture the unique scenery of the hanok buildings and Namsan Seoul Tower at a distance in a single frame. Bukchon Hanok Village is a residential neighborhood, so one should not disrupt the residents’ privacy or enter the residents’ houses without permission.
When starting from Gyeongbokgung Palace and coming up the road via the Bukchon Hanok Village Information Center, one soon finds a curiously fragrant spot at the entrance to an alleyway. The fragrance comes from the brand shop “GRANHAND.,” a hip Korean fragrance brand that enjoys considerable popularity among the members of Gen Z in Korea. GRANHAND. has eight stores across Seoul. Bukchon’s branch, established in 2014 as the brand’s first store, is also the only GRANHAND. store set in a hanok building. The store offers a range of fragrance products, from perfumes to diffusers, candles, and oils. GRANHAND. is famous for describing its fragrances like works of literature. Unfortunately, these descriptions are not available in languages other than Korean. Visitors can test the fragrances to search for their favorite among the many offered in the store. The earthenware pot-shaped candle, in particular, is only offered in the Bukchon branch, so it makes for a great souvenir or a gift.
One can find a unique restaurant serving gukbap (rice soup), a Korean soul food, at the alley that leads to the National Museum of Modern and Contemporary Art, Seoul. It is ANAM, a Bib Gourmand restaurant included in the MICHELIN Guide Seoul 2024. Koreans often associate “pork and rice soup” with white or red soup, but the one served in ANAM is green in color, which comes from the oil used to flavor the soup. In winter, the oil is made with Cheongyang chili pepper and kale, while in summer, the oil features Cheongyang chili pepper and pigweed. The oil imbues the soup with a rich fragrance of vegetables. One can also add cilantro to taste.
After a meal, head to Onion Anguk for sweet desserts and tea. This bakery café is housed in a hanok space refined with contemporary sensibilities. There are terrace and table seats, but the most popular seats in the café are those in the wood-floor hall, where one can sit on the floor. Another claim to fame is its baked goods menu, represented by the Pandoro and Ang Butter (bread with red bean paste and thick butter slices). Add an iced Americano or their signature milk tea to add a layer of richness to the desserts.

korean-electronics.com| Blog Magazine of korean electronics, brands and Goods

Korea’s Exports Continue their Growth Trend in March

https://korean-electronics.com//inquiry

Recording trade surplus of $4.28 billion
Korea’s exports in March continued their growth trend for the sixth consecutive month despite a decrease in the number of working days, marking the tenth consecutive month of trade surplus. Semiconductor exports, the country’s largest export item, drove this growth by achieving their highest performance in 24 months.
According to the nation’s Ministry of Trade, Industry and Energy, exports in March totaled $56.56 billion, a 3.1% increase year-on-year, while imports recorded $52.28 billion, a 12.3% decrease over the same period. Consequently, the trade balance ― exports minus imports ― reached $4.28 billion, marking a streak of surpluses for the tenth consecutive month.

March exports were very positive, increasing compared to the previous year despite a 1.5 working days decrease (two-day on weekdays). Average daily exports, adjusted for working days, also recorded $2.51 billion ― a 9.9% increase from the previous year.
This trade surplus was the result of increased exports in seven of the 15 major export items. In particular, IT items (semiconductors, displays, computers, and wireless communication devices) led the nation’s exports by recording positive growth for the first time in 24 months since March 2022.
Exports of semiconductors, the largest export item, reached $11.7 billion in March ― marking the highest performance in 24 months since March 2022 ($13.1 billion) and continuing a positive trend for five consecutive months.
Exports of displays increased by 16.2% year-on-year, showing an upward trend for eight consecutive months, while computer SSDs rose by 24.5%, marking three consecutive months of growth.
Exports of wireless communication devices increased by 5.5%, breaking a three-month negative trend and turning positive.
Meanwhile, exports of ships surged by a massive 102.1%, continuing their positive trend for eight consecutive months. Exports of biohealth products also rose by 10.0%, marking five consecutive months of growth. In addition, exports of petroleum products also turned positive after just one month.
By region, exports to China (+0.4%), Korea’s largest export destination, recorded positive growth in March, following January. Notably, the daily average export figure ($470 million), adjusted for working days, increased by 7.1%, maintaining a positive trend for four consecutive months since December of last year.
Exports to the United States reached $10.9 billion (+11.6%), recording a double-digit growth rate and continuing an upward trend for eight consecutive months, setting a new record for the highest export value ever for the month of March. Meanwhile, exports to Central and South America (+14.4%) also continued a positive trend this year, increasing for three consecutive months.

korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Beyond the Hallyu Wave: K-Culture Brands Emerge as a Global Economic Powerhouse

https://korean-electronics.com//inquiry

South Korea’s cultural industries have evolved far beyond a pop-culture phenomenon into a pillar of the national economy.
According to the 2025 Content Industry Survey by the Ministry of Culture, Sports and Tourism, Korea’s content-industry exports reached a record $14.07 billion in 2024, showing a 5.5% increase year on year.
Total Hallyu-related exports — spanning content, consumer goods, and tourism — amounted to $15.18 billion. The production-inducement effect was estimated at KRW37.62 trillion, and the employment-creation effect stood at 175,381 jobs. From K-Pop albums and Netflix dramas, to instant noodles, and biosimilar drugs, K-Culture brands are now reshaping global trade patterns in tangible, measurable ways.
Korea’s content industry posted aggregate revenue of KRW157.40 trillion in 2024, up 2.1% from the prior year. Meanwhile, the number of firms rose 2.4% to 120,875, while employment grew by 3.4% to 688,121.
Exports produced a trade surplus of $13.16 billion, while Games dominated the export mix at $8.50 billion (60.4%), followed by music at $1.80 billion and broadcasting and video at $1.26.

K-Pop enters a new chapter as BTS makes a huge comeback
Music-industry exports totaled $1.80 billion in 2024, although physical album sales showed a correction. K-pop album sales fell to 93.28 million copies, a 19.4% decline and the first drop in a decade.

Meanwhile, album exports to Japan fell by 24.7% to $89.79 million. Several European markets also contracted, including: the Netherlands by 35.4%, France by 17.2%, and the United Kingdom by 15.7%. Among major companies, SM Entertainment recorded revenue of KRW989.9 billion, while YG Entertainment swung to an operating loss of KRW20.5 billion based on revenue of KRW364.9 billion.
In March 2026, BTS released its fifth studio album, ARIRANG, marking their triumphant return as a full seven-member group after nearly four years. The industry felt the impact immediately as pre-orders shattered all records, exceeding five million copies within the first week alone.
The album’s dominance was solidified on the Billboard charts, where ARIRANG debuted at No. 1 on the Billboard 200, making BTS the first group in history to secure seven chart-topping albums this decade.
The title track simultaneously conquered the Billboard Hot-100, fueled by unprecedented streaming numbers; the lead single held the top spot on Spotify’s Daily Top-Songs Global for a record-breaking week, while the group became the first Asian act to see an entire album sweep the top of Apple Music’s Global charts.
To celebrate these achievements, a massive comeback concert at Gwanghwamun was live-streamed via Netflix to 190 countries, trending at number one in over 80 regions.
Their subsequent world tour, covering 34 cities and 79 shows, has officially set the all-time record for the highest-grossing single tour by a K-pop act. IBK Investment and Securities estimated direct revenue at approximately KRW2.9 trillion, with broader economic effects—including tourism, lodging, and dining — exceeding KRW3 trillion.

How Korean dramas conquered every Netflix chart that matters
Broadcasting and video revenue reached KRW24.99 trillion in 2024, with exports of $1.26 billion. Broadcast-content exports grew from $336.02 million in 2014 to $1.05 billion in 2023.
Drama accounted for 92.2% of finished-program exports. North America was the largest market at $171.53 million; the greater China market shrank to $26.22 million, from $109.63 million in 2014.

Squid Game Season 3, released in July 2025, drew 60.1 million views within three days and topped all 93 Netflix markets — a platform first. Cumulative views surpassed 106.3 million within ten days.
Season 1 still holds the all-time Netflix record of 1.65 billion hours in its first four weeks. The franchise’s three seasons rank first through third among non-English titles in Netflix history.
In the first half of 2025, eleven Korean dramas entered Netflix’s global Top 100. “When Life Gives You Tangerines” was named the top Korean drama of 2025 by the American magazine Time.


K-Movie sets sales records across 205 countries
The domestic box office contracted modestly in 2024, with total revenue of KRW1.19 trillion (down 5.3%), though Korean films outperformed at KRW691.0 billion (up 15.5%) and a 58% market share.
Two films surpassed 10 million admissions: “Exhuma” at 11.91 million and “The Roundup: Punishment” at 11.50 million.
Park Chan-wook’s latest film achieved pre-sales in 205 countries in 2025, surpassing the 2023-country record set by Parasite and generating overseas revenue of approximately KRW17.0 billion.
Total Korean film exports in 2023 stood at $79.22 million according to the Korean Film Council, with finished-work exports of $62.16 million, the third-highest figure on record.

What comes next for K-Culture?
K-Culture brands have entered a new phase defined by structural diversification rather than any single breakout success.
K-Gaming and K-Drama demonstrated their platform-era competitiveness through the dominance of content exports and Netflix viewing records, respectively.
The BTS comeback’s estimated economic impact of more than KRW3 trillion illustrates that K-Culture now generates multiplier effects across tourism, consumer goods, and services that extend far beyond the cultural sector itself.

korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Homecare Devices

https://korean-electronics.com//inquiry

[INQ. NO. 2604C08] WON MEDCO is a subsidiary of WONTECH, a company specializing in medical aesthetics, and developing and supplying homecare devices and functional cosmetics based on energy technology for hospital medical devices.
Leveraging WONTECH’s accumulated expertise in hospital equipment ― including ultrasound, radio frequency (RF), and lasers ― WON MEDCO is building a product portfolio that reinterprets the technical concepts of professional treatment areas to enable their application in the home.
Through an integrated development approach that designs and plans cosmetics linked to devices, rather than using the devices in isolation, WON MEDCO proposes comprehensive homecare solutions. Leveraging its strengths in quality control and technological stability derived from medical-device manufacturing experience, WON MEDCO is simultaneously expanding into both B2B and B2C markets.

In the domestic market, WON MEDCO has expanded its distribution and partnerships centered on homecare devices and functional cosmetics. Overseas, it is currently discussing exports and collaborations with clients in major Asian countries, including Hong Kong, Thailand, Vietnam, and Indonesia.
In particular, through participation in Hong Kong Cosmoprof Asia, WON MEDCO established a network with distributors and aesthetics-related firms in the Asian region, and in some countries, test sales and introduction reviews were conducted through local distribution partners. WON MEDCO is expanding its global recognition by continuously participating in overseas exhibitions, focusing on the combined medical and beauty market.
At the recently held KIMES 2026, WON MEDCO clearly projected its identity as a homecare solutions company based on medical device technology. The main objectives of participating in the exhibition were to share the applicability of homecare devices and linked cosmetics with medical device and hospital officials, and to identify new collaboration opportunities with domestic and international buyers and partners. Additionally, WON MEDCO focused on gathering on-site feedback regarding its product portfolio and strengthening technological credibility through specialized medical device exhibitions.
WON MEDCO showcased its ultrasound-based skin-lifting homecare device Ultraskin S, the multi-frequency microcurrent device Petite Glow, and the Hairbeam series, which utilizes low-power laser technology. These products are characterized by designs that adapt medical device technology concepts to a home environment. The company also introduced a lineup of functional cosmetics designed for simultaneous use with the devices, such as the Cryo-Derm Mask and Oligo-Lifting Cream. Thus, it proposed an integrated solution that enhances homecare efficiency through the simultaneous use of devices and cosmetics.

WON MEDCO’s primary target markets are in Asia, including Thailand, Vietnam, Indonesia, and Hong Kong. These countries are evaluated as markets with high growth potential in the homecare and aesthetics sectors, as well as promising increasing demand for medical device-based beauty solutions. The company has designated local distributors, aesthetics-related companies, and partners with hospital networks as key collaboration targets, while also reviewing the possibility of collaboration with overseas home shopping, online platforms, and specialized distribution channels.
WON MEDCO plans to continue developing homecare devices and cosmetics linked to medical-device technology and gradually expand business opportunities in the global market by participating in major medical and beauty exhibitions. The company aims to solidify its competitiveness in the medical device technology-based homecare market by strengthening brand awareness and distribution networks through participation in overseas exhibitions such as Cosmoprof Asia and IMCAS Asia.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Digital Therapeutic Device for Improving Nicotine-Use Disorders

https://korean-electronics.com//inquiry

[INQ. NO. 2604E07] Innerwave Inc. is a software technology company that has grown through extensive experience in providing IT services both for public institutions and major corporations. Through continuous research and development, the company has expanded into the digital healthcare sector ― focusing on AI-based diagnostic support, treatment, and monitoring solutions, as well as AI healthcare platforms. Leveraging its expertise, Innerwave has concentrated on digital medical device development and related services.
Recently, Innerwave received regulatory approval from the Ministry of Food and Drug Safety (MFDS) in Korea for its digital therapeutic device for nicotine-use disorders, under the brand name of Dr. JinNicojini. This product is a mobile app–based digital therapy prescribed to patients after being diagnosed by psychiatric or family medicine specialists. It is structured as an eight-week program grounded in Cognitive Behavioral Therapy (CBT), combining coping strategies for nicotine cravings with motivational-enhancement training to support patient self-management in daily life.

Dr. JinNicojini is a product developed to apply cutting-edge technology through innovative medical device approval ― and it has secured content differentiation based on personalized features. The app delivers personalized content through a stepwise eight-week treatment protocol designed to facilitate behavioral change. By collecting and analyzing digital patient data, it supports adherence monitoring and sustained engagement throughout the treatment process. It is significant in that it is a digital therapeutic device that has obtained regulatory approval in Korea, with the goal of improving people’s nicotine-use disorders.
Building on its experience in developing disease-management applications and patient-management platforms for high-level general hospitals, Innerwave plans to expand its domestic clinical references following commercialization. By promoting the adoption of its innovative medical technology in healthcare institutions, the company aims to accumulate real-world clinical cases and strengthen synergies with its broader AI healthcare platform business.
For its overseas expansion strategy, Innerwave has set the German Digital Health Application (DiGA) market as its primary target. To this end, it is preparing to obtain CE MDR certification, as it believes Germany is a market where the regulatory integration of digital therapeutic devices can occur relatively quickly compared to other countries. After securing sufficient domestic references, we plan to pursue a phased expansion into the European and Southeast Asian markets.
Innerwave plans to expand its portfolio of disease-specific digital therapeutic devices based on its digital medical-device development service capabilities and AI-based platform technology.
Starting with Dr. JinNicojini Genie, the company intends to advance its technological competitiveness and business model in the field of digital therapy, and accelerate its entry into the global digital healthcare market.
Innerwave has obtained regulatory approval for software medical devices, achieving development milestones in digital medical devices, mobile health, and AI disease prediction systems—backed by AI-based development infrastructure and clinical data from medical institutions. “We are committed to driving global digital biohealth innovation through our comprehensive one-stop integrated service utilizing medical platforms, AI, and Big Data Cloud technologies,” remarked the company’s CEO.

korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Digital Therapeutics

https://korean-electronics.com//inquiry

[INQ. NO. 2604E06] Founded in 2016 as a spin-off from Samsung Electronics, WELT specializes in digital therapeutics, developing digital-healthcare solutions that combine medical expertise with advanced IT technologies based upon the concept of ‘Wellness Technology.’ The company adheres to the core principle of developing clinically validated software medical devices and has expanded its business based on products that have demonstrated safety and efficacy through regulatory approval.
WELT has developed digital therapeutics for insomnia and eating disorders, and is advancing an ‘AI Combo Drug’ strategy that integrates digital treatment with conventional pharmaceutical therapies. By leveraging AI to analyze patient data, the company aims to optimize medication timing and manage treatment adherence, embedding digital technology throughout the entire patient-care journey.
In 2023, WELT obtained approval from Korea’s Ministry of Food and Drug Safety (MFDS) for its insomnia treatment, digital therapeutic SleepQ, establishing a foundation for commercialization in Korea. The company has since collaborated with pharmaceutical firm Handok to expand prescriptions and distribution across domestic medical institutions, promoting a new treatment approach that combines digital therapeutics with conventional medication.

Mobile-based Digital Therapeutic Treatment
SleepQ is a mobile-based digital therapeutic treatment that delivers Cognitive Behavioral Therapy for Insomnia (CBT-I), traditionally administered in person at hospitals. Designed as a six-week treatment program prescribed by medical professionals, SleepQ analyzes patients’ sleep diaries and behavioral data to provide personalized treatment plans.
The platform integrates core CBT-I components such as sleep restriction, stimulus control, cognitive restructuring, relaxation therapy, and sleep-hygiene education. Through a connected system comprising a patient app and a clinician dashboard, healthcare providers can monitor and manage the treatment process efficiently.

Clinical trial results have demonstrated its effectiveness. After seven weeks of treatment, patients using SleepQ showed an average 15.14% improvement in sleep efficiency and a reduction of over 55% in sleep onset latency, confirming meaningful improvements in sleep outcomes.
WELT recently also showcased DrugOS, its AI-powered drug optimization platform. DrugOS analyzes patients’ physiological and behavioral data in order to recommend optimal medication timing and dosage adjustments tailored to changes in the patient’s condition.
DrugOS implements a ‘Just-in-Time’ medication-management model by identifying disease progression patterns and optimizing medication schedules accordingly. An AI agent continuously interacts with patients to collect additional data, refining treatment strategies over time. This approach enables pharmaceutical companies to enhance therapeutic outcomes by integrating digital technology with existing drugs, without altering the drugs themselves.
In recognition of its technological innovation, WELT received a CES Innovation Awards 2026 honor, drawing global attention in the digital healthcare sector.
WELT is actively expanding into global markets. In Europe, the company has established a local subsidiary in Germany, and is conducting clinical trials for adult insomnia patients in collaboration with Charité – Universitätsmedizin Berlin, one of Europe’s largest university hospitals. WELT has also secured CE certification and ISO 27001 certification, thereby reinforcing its data security and medical device quality-management systems.

In the United States, WELT is expanding its partnerships with global pharmaceutical companies through board-level engagement with the American Telemedicine Association (ATA) and is strengthening its digital healthcare ecosystem through joint research with Oura Health.
In the Middle East, the company is exploring market entry opportunities through discussions with regulatory authorities in the UAE and engaging potential partners at global exhibitions such as WHX Dubai.
Looking ahead, WELT plans to enhance SleepQ with expanded AI capabilities in SleepQ 2.0 and broaden its digital therapeutic pipeline beyond insomnia to include eating disorders, migraines, diabetes, hypertension, and other chronic conditions.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

AI-based Software as a Medical Device

https://korean-electronics.com//inquiry

[INQ. NO. 2604E05] a.cure Co., Ltd. is a digital healthcare company developing AI models that predict disease risk based on voice analysis. Established in June 2024 by a team with experience in developing Korea’s first digital therapeutic device, Somzz, the company is currently advancing by developing AI-based Software as a Medical Device (SaMD), Heart to Voice, designed to analyze the voices of heart-failure patients and high-risk groups. The solution aims to detect early warning signs, prevent emergency events, and reduce hospital readmissions.
Rather than focusing on a single product, a.cure is building a comprehensive digital medical ecosystem that spans early screening ―> diagnostic support ―> post-discharge monitoring. In the long term, the company plans to integrate traditional pharmacological treatments such as diuretics, smartphones, and mobility services to create cross-industry healthcare synergy.
a.cure is currently conducting exploratory clinical trials to further refine Heart to Voice. In the first half of this year, a.cure is advancing with the development of a 90-day prescription-based monitoring AI SaMD for heart failure patients following hospital discharge. In the second half of the year, the company aims to apply for approval through the Korean Ministry of Food and Drug Safety’s Integrated Review Program for Innovative Medical Devices.

Global expansion efforts are also underway. In the first half of the year, a.cure plans to conduct Proof-of-Concept (PoC) projects in collaboration with Medstown in India and PMK Group in Singapore, integrating Heart to Voice into local chronic-disease management platforms. In the second half of 2026, the company intends to apply for the U.S. FDA Breakthrough Devices Program (BDP).
a.cure recently unveiled its 90-day prescription monitoring AI SaMD for post-discharge heart failure patients, and is currently seeking domestic and international distribution and sales partners. The company will conduct product demonstrations and technical briefings targeting pharmaceutical companies, diagnostic firms, and digital health platform operators, while exploring strategic collaborations for overseas PoCs and commercialization.

Digital Cardiopulmonary Product
Heart to Voice is a digital medical product that analyzes approximately 10 seconds of speech using only a smartphone, without requiring additional medical equipment. The AI quantifies biological signals embedded in vocal data ― such as breathing patterns, subtle vocal tremors, and acoustic energy distribution ― closely related to cardiopulmonary function. Based on this analysis, heart-failure severity is classified into four stages ― Normal, Mild, Moderate, and Severe. Exploratory clinical trials have demonstrated predictive performance with an AUC of approximately 95%.

Because the solution is non-invasive and allows for repeated measurements, it can be used in daily life outside the hospital setting. This makes it particularly suitable for continuous monitoring after discharge and for early detection in high-risk populations, positioning it as a next-generation digital-health technology.
Globally, heart failure affects an estimated 120 million people. Approximately 24 million patients are located across five major markets: Korea, the United States, China, Japan, and Singapore. Considering patient population size, as well as digital health adoption, and healthcare accessibility, a.cure has identified the United States, Japan, China, India, Indonesia, and Singapore as key target markets. The company plans direct SaMD entry into the United States and Japan, while pursuing a phased market approach in China, India, Indonesia, and Singapore through partnerships with chronic-disease management platforms based on an “early cardiac-risk detection” wellness service model.
“We will continue enhancing the accuracy of our AI-based heart failure severity model and expanding global validation datasets to strengthen our technological credibility. Through expanded domestic and international distribution partnerships and participation in major global exhibitions ― including MEDICA 2026, SWITCH 2026, and CES 2027 (Innovation Awards application) ― we will accelerate our growth as a global leader in medical AI,” explained the company’s CEO.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods